HACL1
Basic information
Region (hg38): 3:15560699-15601852
Previous symbols: [ "HPCL" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HACL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 38 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 2 | |||||
Total | 0 | 0 | 38 | 11 | 5 |
Variants in HACL1
This is a list of pathogenic ClinVar variants found in the HACL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-15560857-G-A | HACL1-related disorder | Likely benign (Mar 18, 2019) | ||
3-15560869-A-G | not specified | Uncertain significance (Feb 15, 2023) | ||
3-15563368-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
3-15563369-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
3-15563448-G-A | HACL1-related disorder | Likely benign (Jul 01, 2022) | ||
3-15563496-C-T | not specified | Uncertain significance (Mar 22, 2023) | ||
3-15563515-G-A | not specified | Uncertain significance (Mar 08, 2024) | ||
3-15563534-T-C | not specified | Uncertain significance (Sep 26, 2023) | ||
3-15564556-A-G | Likely benign (Jul 01, 2022) | |||
3-15567878-C-G | not specified | Uncertain significance (Nov 14, 2023) | ||
3-15567909-C-A | not specified | Uncertain significance (Apr 25, 2023) | ||
3-15567912-T-C | HACL1-related disorder | Likely benign (Mar 20, 2019) | ||
3-15567937-A-G | not specified | Uncertain significance (May 14, 2024) | ||
3-15567941-C-A | HACL1-related disorder | Likely benign (Apr 25, 2023) | ||
3-15567941-C-T | not specified | Likely benign (Feb 12, 2024) | ||
3-15567945-A-C | HACL1-related disorder | Likely benign (Jun 11, 2019) | ||
3-15567979-G-C | not specified | Uncertain significance (Oct 12, 2021) | ||
3-15567997-T-C | not specified | Uncertain significance (Dec 15, 2022) | ||
3-15567998-C-T | not specified | Uncertain significance (Oct 27, 2023) | ||
3-15568433-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
3-15568465-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
3-15568502-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
3-15568516-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
3-15568559-T-C | not specified | Uncertain significance (May 12, 2024) | ||
3-15568563-C-T | HACL1-related disorder | Benign (May 15, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HACL1 | protein_coding | protein_coding | ENST00000321169 | 17 | 41128 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.48e-12 | 0.654 | 125593 | 0 | 154 | 125747 | 0.000613 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0436 | 321 | 319 | 1.01 | 0.0000158 | 3803 |
Missense in Polyphen | 83 | 87.66 | 0.94684 | 979 | ||
Synonymous | 0.0645 | 107 | 108 | 0.992 | 0.00000536 | 1094 |
Loss of Function | 1.53 | 22 | 31.2 | 0.705 | 0.00000132 | 397 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00190 | 0.00190 |
Ashkenazi Jewish | 0.000410 | 0.000397 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000585 | 0.000571 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.000501 | 0.000457 |
Other | 0.00118 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes a carbon-carbon cleavage reaction; cleaves a 2-hydroxy-3-methylacyl-CoA into formyl-CoA and a 2-methyl-branched fatty aldehyde.;
- Pathway
- Peroxisome - Homo sapiens (human);Oxidation of Branched Chain Fatty Acids;Refsum Disease;Phytanic Acid Peroxisomal Oxidation;Metabolism of lipids;Metabolism of proteins;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism;Peroxisomal protein import;Fatty acid metabolism;fatty acid α-oxidation III;Phytanic acid peroxisomal oxidation;fatty acid α-oxidation
(Consensus)
Recessive Scores
- pRec
- 0.0787
Intolerance Scores
- loftool
- 0.937
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.73
Haploinsufficiency Scores
- pHI
- 0.0922
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.799
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hacl1
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- fatty acid alpha-oxidation;protein targeting to peroxisome;protein complex oligomerization
- Cellular component
- peroxisome;peroxisomal matrix;cytosol
- Molecular function
- magnesium ion binding;signaling receptor binding;protein binding;carbon-carbon lyase activity;thiamine pyrophosphate binding;identical protein binding;cofactor binding